These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23057579)

  • 1. The frequency of cerebral microbleeds increases with CHADS(2) scores in stroke patients with non-valvular atrial fibrillation.
    Song TJ; Kim J; Lee HS; Nam CM; Nam HS; Heo JH; Kim YD
    Eur J Neurol; 2013 Mar; 20(3):502-508. PubMed ID: 23057579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores.
    Cha MJ; Kim YD; Nam HS; Kim J; Lee DH; Heo JH
    Eur J Neurol; 2012 Mar; 19(3):473-9. PubMed ID: 21972975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of intracerebral haemorrhage in Chinese patients with atrial fibrillation on warfarin with cerebral microbleeds: the IPAAC-Warfarin study.
    Soo Y; Abrigo JM; Leung KT; Tsang SF; Ip HL; Ma SH; Ma K; Fong WC; Li SH; Li R; Ng PW; Wong KK; Liu W; Lam BYK; Wong KSL; Mok V; Chu WCW; Leung TW;
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):428-435. PubMed ID: 30554138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.
    Mason PK; Lake DE; DiMarco JP; Ferguson JD; Mangrum JM; Bilchick K; Moorman LP; Moorman JR
    Am J Med; 2012 Jun; 125(6):603.e1-6. PubMed ID: 22502952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early neurological outcomes according to CHADS2 score in stroke patients with non-valvular atrial fibrillation.
    Hong HJ; Kim YD; Cha MJ; Kim J; Lee DH; Lee HS; Nam CM; Nam HS; Heo JH
    Eur J Neurol; 2012 Feb; 19(2):284-90. PubMed ID: 21914056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.
    Giralt-Steinhauer E; Cuadrado-Godia E; Ois A; Jiménez-Conde J; Rodríguez-Campello Á; Soriano C; Roquer J
    Eur J Neurol; 2013 Apr; 20(4):623-8. PubMed ID: 22834861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
    Lip GY; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J;
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):31-8. PubMed ID: 23390125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema.
    Charidimou A; Boulouis G; Shams S; Calvet D; Shoamanesh A;
    J Neurol Sci; 2017 Jul; 378():102-109. PubMed ID: 28566143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation.
    Umemura T; Mashita S; Kawamura T
    PLoS One; 2020; 15(9):e0238456. PubMed ID: 32941455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study.
    Moutzouri E; Glutz M; Abolhassani N; Feller M; Adam L; Gencer B; Del Giovane C; Bétrisey S; Paladini RE; Hennings E; Aeschbacher S; Beer JH; Moschovitis G; Seiffge D; De Marchis GM; Coslovsky M; Reichlin T; Conte G; Sinnecker T; Schwenkglenks M; Bonati LH; Kastner P; Aujesky D; Kühne M; Osswald S; Fischer U; Conen D; Rodondi N
    Int J Stroke; 2023 Dec; 18(10):1219-1227. PubMed ID: 37243540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHA(2)DS(2)-VASc versus CHADS(2) for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry.
    Piyaskulkaew C; Singh T; Szpunar S; Saravolatz L; Rosman H
    J Thromb Thrombolysis; 2014 May; 37(4):400-3. PubMed ID: 23943340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation.
    Sandhu RK; Bakal JA; Ezekowitz JA; McAlister FA
    Heart; 2011 Dec; 97(24):2046-50. PubMed ID: 22076011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Risk Factors of Cerebral Microbleeds in Patients with Nonvalvular Atrial Fibrillation: An Enhanced T2*-Weighted Angiography Imaging Study.
    Li Z; Cao L; Dong W; Zhang J; Wang C; He X; Huang W; Li Y; Zhao M
    Eur Neurol; 2019; 81(3-4):112-119. PubMed ID: 31185466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of cerebral microbleeds and risk of adverse outcomes in atrial fibrillation: a systematic review and meta-analysis.
    Corica B; Romiti GF; Raparelli V; Cangemi R; Basili S; Proietti M
    Europace; 2022 Oct; 24(9):1395-1403. PubMed ID: 35244694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2) , CHA(2) DS(2) -VASc score, underuse of oral anticoagulation, and implications for preventive measures.
    Palm F; Kleemann T; Dos Santos M; Urbanek C; Buggle F; Safer A; Hennerici MG; Becher H; Zahn R; Grau AJ
    Eur J Neurol; 2013 Jan; 20(1):117-23. PubMed ID: 22788384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus.
    Wasmer K; Köbe J; Dechering D; Milberg P; Pott C; Vogler J; Stypmann J; Waltenberger J; Mönnig G; Breithardt G; Eckardt L
    Clin Res Cardiol; 2013 Feb; 102(2):139-44. PubMed ID: 22983022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CHA(2)DS(2)-VASc score reflects clinical outcomes in nonvalvular atrial fibrillation patients with an initial cardioembolic stroke.
    Deguchi I; Hayashi T; Ohe Y; Kato Y; Nagoya H; Fukuoka T; Maruyama H; Horiuchi Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e343-6. PubMed ID: 23523201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
    Coppens M; Eikelboom JW; Hart RG; Yusuf S; Lip GY; Dorian P; Shestakovska O; Connolly SJ
    Eur Heart J; 2013 Jan; 34(3):170-6. PubMed ID: 23018151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
    Lopes RD; Al-Khatib SM; Wallentin L; Yang H; Ansell J; Bahit MC; De Caterina R; Dorian P; Easton JD; Erol C; Ezekowitz JA; Gersh BJ; Granger CB; Hohnloser SH; Horowitz J; Hylek EM; McMurray JJ; Mohan P; Vinereanu D; Alexander JH
    Lancet; 2012 Nov; 380(9855):1749-58. PubMed ID: 23036896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chinese subgroup analysis of the global anticoagulant registry in the FIELD (GARFIELD) registry in the patients with non-valvular atrial fibrillation].
    Sun Y; Hu D; ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Oct; 42(10):846-50. PubMed ID: 25549561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.